Fundraising Fox

D&D Pharmatech

Korea, Republic of corporation · 3 known investors

ddpharmatech.com ↗

DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations. The company aims to build a global biotech business through innovative drug development technology.

Biotech

Founders & leadership

SL
Seulki LeeExecutive Officer, Director
SL
Sungmook LimExecutive Officer, Director
DS
Daehyun ShinDirector
SH
Seol-Heui HanDirector
SL
Seungwon LimDirector
SH
Sunghoon HongExecutive Officer, Director

Investors · 3

DAYLI PartnersSeoul
LB InvestmentSeoul
Octave Ventures LlcHenderson

Reported raises · per SEC filings

Form D private placements
▶$10.8MraisedAug 2025 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Seulki LeeExecutive Officer, Director
  • Sungmook LimExecutive Officer, Director
  • Daehyun ShinDirector
  • Seol-Heui HanDirector
  • Seungwon LimDirector
  • Sunghoon HongExecutive Officer, Director
Offering amount
$10.8M
Amount sold
$10.8M
First sale
Jun 2025
Incorporated
Corporation, Korea, Republic Of
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news